Lucile Regard - Search Results

Year	Number of Results
2014	1
2017	1
2018	4
2019	1
2020	2
2021	7
2022	7
2023	5
2024	1

1

CFTR Modulators in People with Cystic Fibrosis: Real-World Evidence in France.

Regard L, Martin C, Burnet E, Da Silva J, Burgel PR. Regard L, et al. Cells. 2022 May 28;11(11):1769. doi: 10.3390/cells11111769. Cells. 2022. PMID: 35681464 Free PMC article. Review.

2

The Ongoing Quest for Predictive Biomarkers in Chronic Obstructive Pulmonary Disease.

Regard L, Roche N, Burgel PR. Regard L, et al. Am J Respir Crit Care Med. 2023 Sep 1;208(5):511-513. doi: 10.1164/rccm.202306-0957ED. Am J Respir Crit Care Med. 2023. PMID: 37478331 Free PMC article. No abstract available.

3

Cystic Fibrosis in 2021: "The Times They Are A-Changin".

Regard L, Martin C, Burgel PR. Regard L, et al. Arch Bronconeumol. 2022 Jul;58(7):536-538. doi: 10.1016/j.arbres.2021.09.011. Epub 2021 Oct 1. Arch Bronconeumol. 2022. PMID: 35312571 English, Spanish. No abstract available.

4

COVID-19 after 18 months: Where do we stand?

Chassagnon G, Regard L, Soyer P, Revel MP. Chassagnon G, et al. Among authors: regard l. Diagn Interv Imaging. 2021 Sep;102(9):491-492. doi: 10.1016/j.diii.2021.06.003. Epub 2021 Jun 18. Diagn Interv Imaging. 2021. PMID: 34183299 Free PMC article. No abstract available.

5

The Changing Epidemiology of Cystic Fibrosis: The Implications for Adult Care.

Burgel PR, Burnet E, Regard L, Martin C. Burgel PR, et al. Among authors: regard l. Chest. 2023 Jan;163(1):89-99. doi: 10.1016/j.chest.2022.07.004. Epub 2022 Jul 16. Chest. 2023. PMID: 35850286 Review.

6

Inhaled therapy, cardiovascular risk and benefit-risk considerations in COPD: innocent until proven guilty, or vice versa?

Regard L, Burgel PR, Roche N. Regard L, et al. Eur Respir J. 2023 Feb 9;61(2):2202135. doi: 10.1183/13993003.02135-2022. Print 2023 Feb. Eur Respir J. 2023. PMID: 36758999 No abstract available.

7

Acute and chronic non-pulmonary complications in adults with cystic fibrosis.

Regard L, Martin C, Chassagnon G, Burgel PR. Regard L, et al. Expert Rev Respir Med. 2019 Jan;13(1):23-38. doi: 10.1080/17476348.2019.1552832. Epub 2018 Nov 30. Expert Rev Respir Med. 2019. PMID: 30472915 Review.

8

Cured bronchi! Extending the use of nebulised hypertonic saline outside of cystic fibrosis?

Martin C, Regard L, Burgel PR. Martin C, et al. Among authors: regard l. Eur Respir J. 2018 May 17;51(5):1800755. doi: 10.1183/13993003.00755-2018. Print 2018 May. Eur Respir J. 2018. PMID: 29773609 Free article. No abstract available.

9

CFTR Modulators: Current Status and Evolving Knowledge.

Regard L, Martin C, Da Silva J, Burgel PR. Regard L, et al. Semin Respir Crit Care Med. 2023 Apr;44(2):186-195. doi: 10.1055/s-0042-1758851. Epub 2022 Dec 19. Semin Respir Crit Care Med. 2023. PMID: 36535667 Free article.

10

Change in Lung Function after Initiation of Elexacaftor-Tezacaftor-Ivacaftor: Do Not Forget Anatomy!

Martin C, Regard L, Chassagnon G, Burgel PR. Martin C, et al. Among authors: regard l. Am J Respir Crit Care Med. 2022 Jun 1;205(11):1365-1366. doi: 10.1164/rccm.202112-2852LE. Am J Respir Crit Care Med. 2022. PMID: 35358030 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

25 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year